See also this year's filing and all EDGAR filings for this company.
PDF Report 0001596062_2019_Q_BioMed_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.009770907353903253, 'aggregate_val': 9019673, 'exp_sum': 9108673, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 5781613, 'ResearchAndDevelopmentExpense': 3238060, 'remainder_Expenses': 89000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001596062')"} |
Graph
Absolute values for 0001596062, Q BioMed Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,696,913 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 500,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 429,369 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,873,272 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,781,613 |
| 9 | ResearchAndDevelopmentExpense | 3,238,060 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,196,913 |
| 1 | Liabilities | 3,302,641 |
| 2 | Expenses | 9,019,673 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -105,728 |
| 5 | NetIncome | -9,019,673 |
| 6 | ComprehensiveNetIncome | -9,019,673 |
| 7 | BaseVar | 7,759,614 |
| 8 | EconomicCapitalRatio | -2.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
